3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
70
Neoplasms
13
Neoplasm Metastasis
7
Brain Neoplasms
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Osteitis Deformans
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Inflammatory Breast Neoplasms
2
Glioblastoma
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Ependymoma
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Bile Duct Neoplasms
2
Interventions
Temozolomide
30
Radiotherapy
21
Etoposide
9
Carboplatin
9
Bevacizumab
9
Cyclophosphamide
8
Vincristine
7
Radiation
7
Filgrastim
7
Cisplatin
7
Magnetic Resonance Spectroscopy
6
Irinotecan
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
etoposide phosphate
4
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Lomustine
4
Everolimus
4
selpercatinib
3
larotrectinib
3
Thalidomide
3
Paclitaxel
3
Nuclear Medicine Department, Hospital
3
Methotrexate
3
Erlotinib Hydrochloride
3
Chemotherapy, Adjuvant
3
Celecoxib
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Central Nervous System Neoplasms
×
Lapatinib
×
Clear all
No trials found.